Citocromo P450 e interazioni metaboliche (parte I: Basi farmacologiche e potenziali conseguenze cliniche)

Translated title of the contribution: Cytochrome P450 and metabolic drug interactions (part I: Pharmacological principles and potential clinical consequences)

Silvio Caccia, Alessandro Nobili

Research output: Contribution to journalArticlepeer-review

Abstract

This review aims to provide physicians with a "practical" approach to the study of drug-drug interactions, a field where pharmacological studies and regulatory data exceed clinical evidence. The lack of pharmacoepidemiological studies on patients and populations representative of the clinical setting leaves physicians without valid information on the risk/ benefit ratio when two or more drugs are administered at the same time. The first part of the review deals with cytochrome P450 drug metabolism. Drug oxidation plays a major role in bioavailability and clearance and, because of the inducibility and/or inhibition of the catalytic activity of cytochrome P450 enzymes, this is the factor most frequently responsible for drug interactions. The second part discusses the clinical relevance and transferability of pharmacological information in the light of some examples.

Translated title of the contributionCytochrome P450 and metabolic drug interactions (part I: Pharmacological principles and potential clinical consequences)
Original languageItalian
Pages (from-to)146-156
Number of pages11
JournalRicerca e Pratica
Volume20
Issue number4
Publication statusPublished - Jul 2004

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Cytochrome P450 and metabolic drug interactions (part I: Pharmacological principles and potential clinical consequences)'. Together they form a unique fingerprint.

Cite this